PROASSURANCE CORP (PRA) Q3 2025 10-Q Quarterly Report
PROASSURANCE CORP (PRA) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 4, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
PROASSURANCE CORP Q3 2025 10-Q Analysis
Management Discussion & Analysis
- • Revenue $279.6M Q3 2025, down $5.7M (2.0%) YoY; 9 months $828.4M, down $31.9M (3.7%) YoY
- • Operating income down to $7.9M Q3 2025 vs $16.5M YoY; non-GAAP operating margin 5.2% Q3 2025 vs 6.8% YoY (approximation from ratios)
- • Specialty P&C segment net premiums earned $180.8M Q3 2025, down $7.9M (4.2%) YoY; Workers' Comp $41.0M Q3, down $0.9M (2.0%) YoY
- • Net loss ratio higher at 79.8% Q3 2025 vs 72.5% YoY; combined ratio 114.7% Q3 2025 vs 105.6% YoY, driven by Specialty P&C’s 10.4 pts increase in calendar year loss ratio
- • Cash and investments increased to $4.44B Sept 30, 2025, up $70.4M from Dec 31, 2024; debt stable at $422.8M; $175M revolving credit availability for liquidity
- • Management notes 2025 results impacted by ceased syndicate participation, reserve strengthening, and adverse foreign currency fluctuations; near-term outlook cautious with expected ongoing volatility in loss reserves and exposure to medical cost inflation in Workers' Comp segment
Risk Factors
- • New acquisition-related risk due to definitive merger agreement with The Doctors Company and regulatory approval uncertainty
- • Most material update on transaction risks: potential adverse effects of transaction delays, costs, and termination including termination fees
- • Regulatory risk from required approvals, possible additional conditions, and uncertain timing that could halt or modify the acquisition
- • Operational risk from management distraction, key personnel retention challenges, and business disruptions during merger integration
- • Financial risk of stock price volatility and possible increased transaction costs affecting liquidity and valuation
Get deeper insights on PROASSURANCE CORP
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.